SCHEMBL6428994

SCHEMBL6428994

NC(=O)c1ccc(N2CCC(Cc3ccccc3)CC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.70
MAPT P10636 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
HTT P42858 1/20 0.51
GFER P55789 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2952169 0.89 MEN1 (0.65) GAAMAPTKDM4EALDH1A1SLC6A2
SCHEMBL5889215 0.89 ALDH1A1 (0.58) GAAMAPTKDM4EALDH1A1SLC6A2
SCHEMBL6429862 0.86 GAA (0.60) GAAMAPTSLC6A2SLC6A4HTT
SCHEMBL15801112 0.86 MAPT (0.61) GAAMAPTKDM4EALDH1A1SLC6A2
SCHEMBL9051892 0.84 KDM4E (0.51) MAPTKDM4EALDH1A1
Acetamide SCHEMBL27608708 0.83 SLC6A2 (0.65) GAAMAPTKDM4EALDH1A1SLC6A2
SCHEMBL5888881 0.83 ALDH1A1 (0.65) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL6153849 0.82 GAA (1.00) GAAMAPTKDM4EALDH1A1MEN1
SCHEMBL7241082 0.82 SLC6A2 (0.71) MAPTALDH1A1SLC6A2SLC6A4HTT
SCHEMBL9050709 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974766-B N-benzyl-3-phenylamide derivative, pharmaceutical composition containing same and application thereof 中国药科大学 2025-05-16 CN disclosed
CN-115974766-A N-benzyl-3-phenylamide derivatives, pharmaceutical compositions containing same and uses thereof 中国药科大学 2023-04-18 CN disclosed
US-20050222408-A1 Heterocyclic amides with anti-tuberculosis activity UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2005-10-06 US disclosed
WO-2005007625-A2 HETEROCYCLIC AMIDES WITH ANTI-TUBERCULOSIS ACTIVITY THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222408-A1 Heterocyclic amides with anti-tuberculosis activity TST, KAT5, NDUFS5 GAA 4048/4885MAPT 4111/4885KDM4E 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.